Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-associated ligands recognized by the gamma delta T cell receptor (γδTCR) are a diverse group of stress-induced molecules upregulated on tumor cells and infected or stressed cells. These include NKG2D ligands such as MICA, MICB, and ULBPs, butyrophilin family members like BTN3A1, and co-stimulatory ligands such as JAML. Recognition of these ligands by γδTCR—often together with engagement of activating co-receptors—triggers immune responses including cytotoxicity and cytokine production by γδ T lymphocytes, contributing to immune surveillance and antitumor immunity[5][7][9][1][4].
Ligand recognition by γδTCR triggers activation and cytotoxicity of γδ T lymphocytes, leading to tumor cell killing[5][7][9]. Engagement of co-receptors such as NKG2D or BTN3A family enhances or modulates these responses[4][9].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor-associated ligand of gamma delta T cell receptor.